Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,987 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.
Kawasaki R, Oshige A, Yamana K, Hirano H, Nishimura K, Miura Y, Yorioka R, Sanada Y, Bando K, Tabata A, Yasuhara K, Miyazaki Y, Shinoda W, Nishimura T, Azuma H, Takata T, Sakurai Y, Tanaka H, Suzuki M, Nagasaki T, Ikeda A. Kawasaki R, et al. Among authors: tanaka h. Chemistry. 2023 Dec 22;29(72):e202302486. doi: 10.1002/chem.202302486. Epub 2023 Nov 6. Chemistry. 2023. PMID: 37792507
Carborane bearing pullulan nanogel-boron oxide nanoparticle hybrid for boron neutron capture therapy.
Kawasaki R, Hirano H, Yamana K, Isozaki H, Kawamura S, Sanada Y, Bando K, Tabata A, Yoshikawa K, Azuma H, Takata T, Tanaka H, Sakurai Y, Suzuki M, Tarutani N, Katagiri K, Sawada SI, Sasaki Y, Akiyoshi K, Nagasaki T, Ikeda A. Kawasaki R, et al. Among authors: tanaka h. Nanomedicine. 2023 Apr;49:102659. doi: 10.1016/j.nano.2023.102659. Epub 2023 Feb 21. Nanomedicine. 2023. PMID: 36822335
Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy.
Kawasaki R, Hirano H, Yamana K, Oshige A, Nishimura K, Kono N, Sanada Y, Bando K, Tabata A, Yasukawa N, Azuma H, Takata T, Sakurai Y, Tanaka H, Suzuki M, Tarutani N, Katagiri K, Nagasaki T, Ikeda A. Kawasaki R, et al. Among authors: tanaka h. Chembiochem. 2023 Aug 1;24(15):e202300186. doi: 10.1002/cbic.202300186. Epub 2023 Jul 4. Chembiochem. 2023. PMID: 37069129
HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex.
Yamana K, Kawasaki R, Kondo K, Hirano H, Kawamura S, Sanada Y, Bando K, Tabata A, Azuma H, Takata T, Sakurai Y, Tanaka H, Kodama T, Kawamoto S, Nagasaki T, Ikeda A. Yamana K, et al. Among authors: tanaka h. Nanoscale Adv. 2023 Jun 1;5(15):3857-3861. doi: 10.1039/d3na00028a. eCollection 2023 Jul 25. Nanoscale Adv. 2023. PMID: 37496630 Free PMC article.
Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential.
Masunaga SI, Sakurai Y, Tanaka H, Takata T, Suzuki M, Sanada Y, Tano K, Maruhashi A, Ono K. Masunaga SI, et al. Among authors: tanaka h. Int J Radiat Biol. 2019 Dec;95(12):1708-1717. doi: 10.1080/09553002.2019.1666214. Epub 2019 Sep 23. Int J Radiat Biol. 2019. PMID: 31545117
An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness.
Masunaga SI, Sanada Y, Tano K, Sakurai Y, Tanaka H, Takata T, Suzuki M, Ono K. Masunaga SI, et al. Among authors: tanaka h. J Radiat Res. 2020 Nov 16;61(6):876-885. doi: 10.1093/jrr/rraa048. J Radiat Res. 2020. PMID: 32601693 Free PMC article.
14,987 results
You have reached the last available page of results. Please see the User Guide for more information.